Hypothalamic Obesity: Prologue and Promise
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Hypothalamic obesity (HO) frequently occurs following damage to the medial hypothalamic region, encompassing the arcuate nucleus, the paraventricular nucleus, the ventromedial nucleus, the dorsomedial nucleus, and the dorsal hypothalamic area, which are critically involved in the regulation of satiety and energy balance through neural and humoral connections. HO is most commonly described in the context of craniopharyngioma and its treatment, but it can also occur following other suprasellar tumors, radiation, trauma, or a surgical insult to the hypothalamus. A constellation of loss of satiety and a reduction of the metabolic rate, thermogenesis, and physical activity as well as increased vagal tone and hyperinsulinism with insulin and leptin resistance results in rapid weight gain due to a decreased energy expenditure and increased energy storage in adipose cells. To date, no viable long-term solution for HO has been found, due either to the requirement of intact hypothalamic pathways or to significant side effects. Newer therapeutic modalities focused on the unique pathophysiology of this condition offer potential for successful treatment. In this review, we describe the etiology of HO as well as past/current treatment approaches in the categories of hyperinsulinism, surgical approaches, and targeting energy expenditure/anorectic drugs. We conclude by providing an overview of the clinical trials currently underway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From a hormone output standpoint, hypothalamic dysfunction may alter hormone release potentially applicable to body composition and body weight, such as corticotrophin-releasing hormone, dopamine, growth hormone-releasing hormone, somatostatin, gonadotrophin-releasing hormone, and thyrotrophin-releasing hormone [21].”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [21]
In the citing paper
“Largely through the vagus nerve, afferent stomach stretch-fibers after a meal transmit parasympathetic signals to the brain and hypothalamus to increase satiety.”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [21]
In the citing paper
“Hypothalamic efferent signals to other parts of the brain may affect hunger and appetite, and may affect thermogenesis, energy expenditure, increase blood pressure, and stimulate lipolysis in adipose tissue [21].”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [21]
In the citing paper
“From a hormone input standpoint, ghrelin from the stomach increases hunger.”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [21]
In the citing paper
“Leptin from adipose tissue may also decrease hunger.”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [21]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Shepherd, G. M., Rode, R. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003114 · Cited by 943
Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro
Kolaczynski, J. W., Nyce, M. R., Considine, R. V., Boden, G., Nolan, J. J., Henry, R., Mudaliar, S. R., Olefsky, J., & Caro, J. F. (1996) · Diabetes · doi:10.2337/diab.45.5.699 · Cited by 700
Müller, H. L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1115 · Cited by 401
Müller, H. L., Gebhardt, U., Teske, C., Faldum, A., Zwiener, I., Warmuth-Metz, M., Pietsch, T., Pohl, F., Sörensen, N., & Calaminus, G. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0158 · Cited by 302
Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial
Lustig, R. H., Hinds, P. S., Ringwald-Smith, K., Christensen, R. K., Kaste, S. C., Schreiber, R. E., Rai, S. N., Lensing, S. Y., Wu, S., & Xiong, X. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030003 · Cited by 299
Müller, H. L., Bueb, K., Bartels, U., Roth, C., Harz, K., Graf, N., Korinthenberg, R., Bettendorf, M., Kühl, J., Gutjahr, P., et al. (2001) · Klinische Pädiatrie · doi:10.1055/s-2001-16855 · Cited by 273
Self-citationLeptin action in the forebrain regulates the hindbrain response to satiety signals
Morton, G. J., Blevins, J. E., Williams, D. L., Niswender, K. D., Gelling, R. W., Rhodes, C. J., Baskin, D. G., & Schwartz, M. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522081 · Cited by 256
BRAY, G. A., & GALLAGHER, T. F. (1975) · Medicine · doi:10.1097/00005792-197507000-00002 · Cited by 231
Pereira, A. M., Schmid, E. M., Schutte, P. J., Voormolen, J. H. C., Biermasz, N. R., Van Thiel, S. W., Corssmit, E. P. M., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02196.x · Cited by 220
Cited by
Frappaz, D., Dhall, G., Murray, M. J., Goldman, S., Faure‐Conter, C., Allen, J. C., Kortmann, R. D., Haas-Kogen, D. A., Morana, G., Finlay, J. L., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab252 · Cited by 169
Roth, C. L., Perez, F. A., Whitlock, K. B., Elfers, C., Yanovski, J. A., Shoemaker, A. H., & Abuzzahab, M. J. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14224 · Cited by 87
“The Energy Balance and Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumours in Hypothalamic Obesity (ECHO) trial was an investigator-initiated multisite, 36-week, double-blind, placebo-controlled randomized trial to evaluate the efficacy and safety of ExQW for BMI reduction in adolescents and young a…”
InfluentialSelf-citationRoth, C. L., Scimia, C., Shoemaker, A. H., Gottschalk, M., Miller, J., Yuan, G., Malhotra, S., & Abuzzahab, M. J. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00087-1 · Cited by 76
Self-citationTheilade, S., Christensen, M., Vilsbøll, T., & Knop, F. K. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14270 · Cited by 82
“Hypothalamic lesions can cause rapidly progressive, severe obesity, which is particularly difficult to treat.(198) Hypothalamic obesity can develop after traumas, tumours or inflammatory diseases perturbing hypothalamic function.”
BackgroundBays, H. E., Fitch, A., Christensen, S., Burridge, K., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100018 · Cited by 68
“Conversely, hormones such as insulin (i.e., from pancreatic beta cells), amylin (i.e., from pancreatic beta cells), and glucagon (i.e., from pancreatic alpha cells), CCK from the small intestine, and GLP-1, oxy-ntomodulin, PYY, and FGF19 from the ileum or large intestine may all reduce hunger [21].”
BackgroundInfluential
Metadata
- Authors
- Abuzzahab, M. J., Roth, C. L., & Shoemaker, A. H.
- Affiliations
- Children’s Minnesota - St. Paul Hospital (US)
- University of Washington (US)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Abuzzahab, M. Jennifer
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2019
- Volume
- 91
- Issue
- 2
- Pages
- 128-136
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2921581269
- Cited by
- 71
- References
- 67
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 14 · 2023: 10 · 2022: 11 · 2021: 16 · 2020: 4 · 2019: 1
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK104936)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- hypothalamic obesity, craniopharyngioma, hypothalamic injury, satiety regulation, energy balance, hyperinsulinism, leptin resistance, energy expenditure, anorectic drugs, surgical treatment, hypothalamic tumors, weight gain
- MeSH terms
- Animals, Arcuate Nucleus of Hypothalamus, Craniopharyngioma, Energy Metabolism, Humans, Obesity, Paraventricular Hypothalamic Nucleus, Pituitary Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypothalamic Obesity: Prologue and Promise. https://app.cochat.ai/papers/10.1159/000496564
- The paper
- Abuzzahab, M. J., Roth, C. L., & Shoemaker, A. H. (2019). Hypothalamic Obesity: Prologue and Promise. Hormone Research in Paediatrics. https://doi.org/10.1159/000496564
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.